Atlas market file ¡ Equity ¡ United States
Ibotta, Inc.IBTA
- Last close
- 35.96
- Change
- +1.81%
- 96-bar range
- 23.845 â 40.485
- As of
- 6 Aug 2026
Ibotta, Inc. is a services-advertising issuer listed as IBTA on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
⎠up candle ⎠down candle
Weekly outlook: the last 104 weekly closes (-37.76% over the window).
Source rail: Yahoo Finance chart API (IBTA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView ¡ provider feed Open view ->
Open the attributed TradingView market view for IBTA. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IBTA public profile
Services-advertising issuer. Ibotta, Inc. is connected to current market context, cited company sources and its retained research file.
Ibotta, Inc. trades as IBTA on NYSE. Ibotta, Inc. (IBTA) has a latest verified close of 35.96, up 1.81%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files IBTA under USA Stocks for browsing.
What changed for Ibotta, Inc. today
Ibotta Inc. reported first-quarter 2026 revenue of $82.5 million, down from the same quarter last year when the company was still burning through cash at a faster clip. The net loss attributable to parent was $10.3 million, with an operating loss of $10.8 million and a diluted loss per share of 43 cents on 24.1 million diluted shares. Those headline losses arrived despite $14.5 million of R&D spend and $3.1 million of capex, which is the kind of math that keeps growth teams busy and shareholders less so.
Ibotta pitches LiveLift⢠as a set of capabilities that help brands drive incremental sales at scale in a more cost-efficient manner, but the filing shows amortisation of capitalised software development costs rose to $1.3 million in the quarter from $1.2 million a year earlier-hardly the definition of cost-efficiency when the company is still losing money. Ad & other revenue fell by $1.7 million, or 15%, driven by reduced client spend on D2C ad products, partially offset by an increase in revenue from data products. The platformâs Ibotta Performance Network is said to reach 200 million consumers through a growing network of publishers, with a claimed 58% incremental sales lift across the network, yet the income statement tells a different story.
The balance sheet carries $479.9 million of assets against $230.9 million of liabilities, leaving $249.0 million of equity and $164.6 million of cash and cash equivalents. Operating cash flow was positive at $30.4 million for the quarter, but thatâs not yet enough to offset the ongoing losses or the cash used in investing activities. The companyâs own Brand Solutions page boasts availability to 100% of Walmart customers, while the filing quietly reports the revenue headwinds in ad products. Retail giants like Walmart and Dollar General are cited as trusting partners, but the numbers show the partnership hasnât yet translated into top-line growth.
For a view of the stockâs recent trading context, see TradingViewâs IBTA chart route for Ibotta Inc. on the NYSE American exchange, where liquidity and volatility remain watch-items rather than guarantees. The chart will reflect the gap between the platformâs promotional narrative and the income statementâs reality, but it wonât change the source facts: revenue softness, ongoing losses, and a balance sheet that funds the gap for now.
What changed in the last month: a flurry of Form 4 filings by insiders and directors in early July, alongside 144 filings that suggest some holders are positioning for liquidity rather than conviction. The companyâs press rail highlights a Thanksgiving giveaway with $100K in prizes, which is colourful but immaterial to the filing-level numbers. The tension sits between the platformâs expanding reach claims and the quarterâs actual revenue and profit outcomes. Evidence that would materially shift the file next: a sustained rebound in ad & other revenue, proof that LiveLift⢠delivers measurable margin improvement, or a filing that shows operating cash flow covering losses without relying on one-off items.
The companyâs core product is the Ibotta Performance Network, marketed to brands and publishers as a way to drive incremental sales at scale. The platformâs public pages claim reach to 200 million consumers and a 58% incremental sales lift, but the latest 10-Q shows ad & other revenue fell 15% year-over-year, driven by reduced client spend on D2C ad products. The filing does not break out segment-level profitability for Brand Solutions versus Publisher Solutions, so the source requires readers to take the networkâs claimed lift on trust while the income statement shows the revenue reality. The companyâs product pages and press rail provide marketing colour and visuals, but the filings remain the only source of verifiable financial outcomes.
Sources & evidence ¡ 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IBTA technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IBTA
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IBTA research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IBTA FAQ
What is Ibotta, Inc. (IBTA)?Ibotta, Inc. (IBTA) has a latest verified close of 35.96, up 1.81%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Ibotta, Inc. (IBTA) has a latest verified close of 35.96, up 1.81%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IBTA?Ibotta, Inc. (IBTA) has a latest verified close of 35.96, up 1.81%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Ibotta, Inc. (IBTA) has a latest verified close of 35.96, up 1.81%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files IBTA under USA Stocks for browsing.
How often is the IBTA page updated?The IBTA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IBTA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IBTA?The IBTA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:IBTA. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The IBTA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:IBTA. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IBTA?Yes. The workstation can open IBTA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IBTA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IBTA page investment advice?No. The IBTA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IBTA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes â
IBTA
Equity ¡ evidence first